Entity

Time filter

Source Type

San Diego, CA, United States

The present application provides compounds of Formula I or salt forms thereof, wherein R


Patent
Ignyta | Date: 2015-05-13

The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.


Patent
Ignyta and Nerviano Medical Science S.R.I. | Date: 2015-02-17

Substituted indazole derivatives of formula (I) or formula 2.(I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.


Patent
Ignyta | Date: 2013-11-12

The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.


The present application provides compounds of Formula I or salt forms thereof, wherein R

Discover hidden collaborations